AAAlberto Goday Arno

Alberto Goday Arno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alberto Goday Arno has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • J. Franch

    1 shared publication
  • J.F. Ascaso

    1 shared publication
  • Josep Maria Corretger

    Down Syndrome Medical Center, Down Syndrome Catalan Foundation, Centre Medic Down de la Fundacio Catalana Sindrome de Down, Barcelona, Spain

    1 shared publication
  • Juan Francisco Cano‐Pérez

    Endocrinology and Diabetes Unit, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain

    1 shared publication
  • Juan José Chillaron‐Jordan

    Endocrinology and Diabetes Unit, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain

    1 shared publication
  • Juana Antonia Flores‐Le‐Roux

    Endocrinology and Diabetes Unit, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain

    1 shared publication

Latest Publications

  • Hyperthyroidism in a population with Down syndrome (DS)

    by Alberto Goday‐Arno, Mariaina Cerda‐Esteva, Juana Antonia Flores‐Le‐Roux, Juan José Chillaron‐Jordan, Josep Maria Corretger, Juan Francisco Cano‐Pérez

    Summary: Background  Thyroid disorders are frequent in patients with Down syndrome (DS). It is well‐known that the prevalence of hypothyroidism is high but data on hyperthyroidism are scarce.Objectives  To assess the prevalence, aetiology, clinical characteristics, evolution and treatment of hyperthyroidism in a population with DS attending a specialized medical centre.Methods  Data were gathered by systematic review of 1832 medical records from the Catalan DS Foundation, in Spain, registered between January 1991 and February 2006. Patients with the diagnosis of hyperthyroidism were identified and data on clinical features, physical examination, laboratory and imaging tests, treatment and evolution were collected.Results  Twelve patients with hyperthyroidism were recorded (6·5 cases/1000 patients with DS). There were 5 males and 7 females, with a mean age at diagnosis of 16·8 years. The most common presenting symptoms were decreased heat tolerance, sweating, increased irritability and weight loss. All patients had diffuse goitre at physical examination and two patients presented with exophthalmia. Clinical diagnosis was confirmed biochemically. Thyroid‐stimulating immunoglobulin levels were raised (mean 128·1 U/l) and imaging tests confirmed the diagnosis of Graves’ disease in all cases. Patients started treatment with carbimazole at diagnosis and after a mean period of 40 months without clinical remission, they required definitive therapy with radioactive iodine. Subjects developed hypothyroidism after radio‐iodine therapy and replacement therapy with levothyroxine was necessary.Conclusions  Hyperthyroidism is more prevalent in patients with DS than in the general population and has no gender predominance. It is caused mainly by Graves’ disease. Anti‐thyroid drugs were not effective in achieving remission and radioactive iodine as a definitive treatment was required in all cases.


  • Riesgo cardiovascular en sujetos con alta probabilidad de síndrome metabólico y resistencia a la insulina. Estudio DESIRE

    by A. Goday, R. Gabriel, J.F. Ascaso, J. Franch, R. Ortega, O. Martínez, N. Lerones